Header Logo

Connection

William Hildebrand to Melanoma, Experimental

Back to Details
This is a "connection" page, showing publications William Hildebrand has written about Melanoma, Experimental.
William Hildebrand
Connection Strength
0.197
Melanoma, Experimental
  1. Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors. J Immunother Cancer. 2022 Oct; 10(10).
    View in: PubMed
    Score: 0.197
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.